Stellantis N.V. (NYSE:STLA) is among the Goldman Sachs EV and Battery Stocks. On February 10, 2026, Freedom Capital analyst Dmitriy Pozdnyakov raised Stellantis N.V. (NYSE:STLA) to Buy from Hold and issued a $9 price target, down from $11.30. The firm released preliminary results showing a sequential rise in auto deliveries. Management announced a strategic shift in response to lower-than-expected EV demand. The firm decreased its projections for 2026-27, even though it still expects a sales revival and m ...

Group 1: Company Performance - Conestoga Capital Advisors reported that Rollins, Inc. (NYSE:ROL) stock closed at $60.92 per share on February 19, 2026, with a one-month return of -3.16% and a 52-week gain of 18.78% [2] - Rollins, Inc. achieved record revenue of $3.8 billion in 2025, reflecting an 11% year-over-year increase [4] - The company demonstrated organic growth of 7.2%, driven by commercial organic growth of 8.4%, and reported strong incremental margins of 35% [3] Group 2: Investment Insights - Rollins, Inc. is characterized as a premier global consumer and commercial services company, providing essential pest control services through brands like Orkin, and remains a core holding due to its defensive characteristics and ability to compound earnings through various economic cycles [3] - Despite the potential of Rollins, Inc. as an investment, the company is not among the 30 most popular stocks among hedge funds, with 48 hedge fund portfolios holding its shares at the end of Q3 2025, up from 42 in the previous quarter [4] - Conestoga Capital Advisors noted that certain AI stocks may offer greater upside potential and carry less downside risk compared to Rollins, Inc. [4]

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. As many believe, US equities experienced solid returns in 2025, with double-digit gains across all major indices, yet underlying conditions revealed extreme volatility and market leadership. A copy of the letter can be downloaded here. In Q4 2025, Conestoga Capital Advisors SMid Cap Strategy trailed the Russell 2500 Growth Index, returning -2.71% vs. 0.33% for the Index. Relative performance fluctuated ...

We recently published 10 Firms Outperform Wall Street With Surprising Gains. Americold Realty Trust Inc. (NYSE:COLD) was one of the best performers on Thursday. Americold bounced back by 15.75 percent on Thursday to finish at $13.89 apiece as investor sentiment was boosted by the company’s upbeat outlook for 2026 despite weak earnings performance last year, supported by the recent appointment of its new chief finance officer (CFO). “Entering 2026, we have developed a list of key priorities that are desi ...

We recently published 10 Firms Outperform Wall Street With Surprising Gains. SSR Mining Inc. (NASDAQ:SSRM) was one of the best performers on Thursday. SSR Mining rallied for a second day on Thursday to hit a nearly 15-year high as investors took heart from a stellar earnings performance last year, supported by the early redemption of its senior convertible notes due 2039. At intra-day trading, the stock jumped to its highest price of $29.68 before trimming a few cents to finish the session just up by 9.4 ...

We recently published 10 Firms Outperform Wall Street With Surprising Gains. Etsy Inc. (NYSE:ETSY) was one of the best performers on Thursday. Etsy snapped a five-day losing streak on Thursday, jumping 9.28 percent to finish at $48.14 apiece as investors took heart from the sale of its secondhand clothing app, Depop, while digesting strong revenues in the fourth quarter and full-year 2025. In a statement, Etsy Inc. (NYSE:ETSY) said that it officially inked a definitive agreement with e-commerce giant eBay ...

Ascendis Pharma (NASDAQ:ASND) is one of the best NASDAQ growth stocks to buy for the next 2 years. On February 11, Ascendis Pharma reported that it nearly doubled its total revenue for 2025 to €720 million, fueled by the rapid global adoption of its core endocrinology products. Q4 was particularly significant, as the company achieved an operating profit of €10 million and generated €73 million in operating cash flow. This was largely driven by YORVIPATH, which brought in €477 million for the full year, and ...

Core Insights - Genmab (NASDAQ:GMAB) is identified as a promising growth stock for the next two years, with a reported total revenue growth of 19% in 2025, reaching $3.7 billion [1][4] - The significant revenue increase is attributed to a 54% rise in sales of proprietary medicines, particularly Abkinley, which generated $468 million, marking a 67% year-over-year increase [1][4] - The company’s royalty portfolio, especially Darzalex, is projected to achieve net sales of up to $16.4 billion in 2026 [1] Company Expansion and Developments - Genmab strategically expanded its operations, highlighted by the acquisition of ProfoundBio and its late-stage asset, Rina-S [2] - The company enhanced its clinical pipeline with three new Phase 3 trials and received FDA approval for Abkinley in second-line follicular lymphoma [2] Clinical Trial Outcomes - Genmab faced challenges with the Phase 3 EPCOR DLBCL-1 trial, where it met progression-free survival goals but did not achieve statistical significance for overall survival [4] - Ongoing discussions with regulatory authorities are addressing trial biases, including the effects of COVID-19 and subsequent therapies [4]

Instacart (Maplebear Inc.) (NASDAQ:CART) is one of the best debt-free mid-cap stocks to buy according to hedge funds. On February 12, Instacart (Maplebear Inc.) (NASDAQ:CART) delivered impressive fourth-quarter and full-year 2025 results that affirmed accelerating growth and improving profitability. Instacart (Maplebear Inc.) (CART) in a Phase of Robust Growth and Improving Profitability The company delivered a 12.3% year-over-year increase in revenue in the fourth quarter to $992 million, while adjusted ...

SM Energy Company (NYSE:SM) is included among the 12 Best Crude Oil Stocks to Buy as Tensions Rise. SM Energy (SM) Completes Merger with Civitas Resources SM Energy Company (NYSE:SM) is an independent energy company focused on the exploration, exploitation, development, acquisition, and production of natural gas and crude oil in the United States. SM Energy Company (NYSE:SM) announced on January 30 that it had closed its all-stock merger with Civitas Resources, creating a larger independent producer tha ...